DRC Kivu 2018–2020: Inside the World's Most Complex Ebola Response

An Outbreak Unlike Any Before

When the 10th DRC Ebola outbreak was declared on August 1, 2018, in North Kivu Province, the global health community immediately recognised the challenge. This was not a remote village outbreak with a handful of cases. North Kivu was:

Home to over 100 armed groups fighting in an active conflict zone
Densely populated: Butembo, the epicentre city, had 800,000 residents
A cross-border hub: connecting DRC to Uganda, Rwanda, and Burundi
An area with deep-rooted mistrust of central government and international organisations

At the time of the outbreak declaration, the DRC had already experienced nine prior Ebola outbreaks. But all previous outbreaks had occurred in rural areas with limited population mobility. Kivu was different in every way that mattered.

Scale and Duration

The final numbers:

Duration: 680 days (August 2018 – June 2020)
Cases: 3,481 (3,317 confirmed + 164 probable)
Deaths: 2,299
Case fatality ratio: 66%
Health zones affected: 29 across North Kivu, South Kivu, and Ituri
Status: WHO declared a Public Health Emergency of International Concern (PHEIC) on July 17, 2019

This was the second-largest Ebola outbreak in history, exceeded only by the 2014–2016 West Africa epidemic.

What Made Kivu So Different

1. Armed Conflict as a Permanent Variable

Eastern DRC has been in a state of chronic armed conflict since the 1990s. During the Kivu outbreak, numerous armed groups — including the Allied Democratic Forces (ADF), Mai-Mai factions, and others — regularly ambushed response teams, killed healthcare workers, and burned Ebola Treatment Centres.

Key incidents:

Butembo ETCs attacked and burned: February and March 2019
WHO epidemiologist shot and killed: April 2019 in Butembo
Katwa Treatment Centre destroyed: Multiple times

The result was periodic shutdowns of contact tracing operations, forced relocation of ETCs, and areas that response teams simply could not safely access. Unknown chains of transmission continued in conflict zones where no surveillance occurred.

2. Community Resistance

Community resistance was arguably the biggest operational challenge — more so even than the violence.

A significant proportion of the population in affected areas:

Did not believe Ebola was real: Some believed it was a fabrication by national authorities or international organisations to siphon aid money
Feared ETCs as places of death: Patients who entered ETCs, cut off from families and with very limited visitor access, often died alone, reinforcing the fear
Trusted traditional healers over hospitals: Many patients were first seen by traditional healers, who were themselves often infected and became amplifiers

Polling conducted in Butembo found that up to 40% of residents at the outbreak’s peak did not believe Ebola was a real disease.

The response invested massively in community engagement — hiring local community health workers, training traditional healers, establishing Community Care Centres that allowed family participation — but trust was slow to build and easily destroyed by incidents of perceived misconduct.

3. Urban Transmission

The concentration of cases in Butembo (population ~800,000) and Katwa introduced transmission dynamics never seen in previous Ebola outbreaks:

High-density housing with shared water sources
Large markets with thousands of daily visitors
Complex social networks with many contacts per case
Motorcycle taxis (boda-bodas) that regularly transported sick patients across health zones

Traditional ring vaccination around individual cases was strained by the scale of contact networks in urban settings. Some confirmed cases had over 200 identified contacts.

4. Electoral Politics

The DRC held presidential elections in December 2018. In Beni and Butembo — key outbreak areas — voting was postponed due to the outbreak, disenfranchising residents. This was perceived as politically motivated, deepening existing mistrust of national government.

What Made Kivu Historic: The Tools Used

Despite the challenges, the Kivu outbreak also marked the first operational deployment of transformative new countermeasures.

Ring Vaccination at Scale

The rVSV-ZEBOV vaccine (Ervebo) was deployed under a “compassionate use” ring vaccination protocol. By the end of the outbreak:

Over 303,000 people vaccinated
Ring vaccination coverage achieved despite violence and resistance
First-ring contacts: 10 days post-vaccination protection
Effectiveness in field conditions estimated at 97.5% (real-world study published in The Lancet)

This was the first time an Ebola vaccine played a significant operational role in outbreak control.

Monoclonal Antibody Treatments

The Kivu outbreak was the site of the PALM randomised controlled trial — a clinical trial comparing four experimental treatments during an active outbreak. Results, published in NEJM in 2019:

Treatment	Mortality (with treatment)
ZMapp	49.7%
Remdesivir	53.1%
mAb114 (now: Ebanga)	35.1%
REGN-EB3 (now: Inmazeb)	33.5%

mAb114 and REGN-EB3 (now branded Ebanga and Inmazeb) demonstrated a survival benefit approaching 20 percentage points over ZMapp. The PALM trial — designed and executed in an active outbreak, amid violence and community resistance — was a landmark achievement in emergency research ethics and operations.

Both treatments were subsequently FDA-approved in 2020 and WHO-prequalified.

Go.Data Contact Tracing Platform

The Kivu outbreak drove the operational scale-up of Go.Data, WHO’s digital contact tracing platform. At peak operations, over 150,000 contacts were registered, and daily follow-up visits were conducted and documented in real time. This experience shaped how contact tracing data systems were used in the subsequent COVID-19 pandemic response.

The PHEIC Declaration: Politics and Science

WHO’s Emergency Committee met four times before declaring the outbreak a Public Health Emergency of International Concern (PHEIC) in July 2019 — nearly a year after the outbreak began.

The decision was controversial. Many global health experts argued that PHEIC criteria were met earlier and that delay reflected political considerations (fear that a PHEIC declaration would disrupt trade and travel to DRC). Others argued that a PHEIC would undermine DRC’s government and not meaningfully change the response.

The eventual PHEIC declaration did accelerate international funding and political attention but did not dramatically change field operations.

How It Ended

The Kivu outbreak did not end with a dramatic breakthrough. It ended through the cumulative effect of sustained response operations gradually reducing transmission faster than new cases were generated.

Key turning points:

Community engagement progress: By late 2019, acceptance of ETC care and vaccination had meaningfully improved
Ring vaccination scale-up: Vaccination of healthcare workers outside the ring (frontline vaccination) dramatically reduced healthcare-associated cases
Reduction in violence: Security improvements in some areas allowed full contact tracing
Outbreak end declared: June 25, 2020

The response cost over US$900 million — the most expensive Ebola response in history.

What Kivu Taught the World

Community trust is not optional: Technical tools (vaccines, treatments, tracing systems) are useless if communities don’t trust them. Community engagement requires local ownership and years of investment — not a communication campaign launched during the outbreak.
Safety of response teams cannot be separated from outbreak control: When responders cannot safely operate, chains of transmission continue. Response security is a core operational issue.
Experimental tools can be ethically deployed during outbreaks: The PALM trial proved that randomised clinical trials can be conducted during active outbreaks, generating evidence while providing care.
Ring vaccination works at scale: The rVSV-ZEBOV vaccine’s field performance in Kivu was decisive evidence of its effectiveness in real operational conditions.
Political contexts shape outbreak dynamics: Elections, governance failures, and community-government relationships are part of the epidemiological landscape.

The 2026 DRC North Kivu outbreak is occurring in the same region, against this backdrop. The lessons of 2018–2020 are not historical — they are directly relevant to the current response.